The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zovirax 200 mg/5 mL Oral Suspension

200 mg/5ml Oral suspension

GlaxoSmithKline (Ireland) LimitedPA1077/084/005

Main Information

Trade NameZovirax 200 mg/5 mL Oral Suspension
Active SubstancesACICLOVIR
Strength200 mg/5ml
Dosage FormOral suspension
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/084/005

Group Information

ATC CodeJ05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
J05AB01 aciclovir

Status

Authorised/WithdrawnAuthorised
Licence Issued24/03/1986
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back